The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Early Detection of Cancers in Low Resource Countries
Official Title: Efficacy of a Combined Program for Early Detection of Breast and Gynecological Cancers in Low Resource Countries
Study ID: NCT01178736
Brief Summary: The purpose of this study is to implement a community-based combined program for early detection of breast, cervical, ovarian and endometrial cancer in low-resource countries delivered through a free standing or a mobile Well Woman Clinic. The goals of this program are to downstage cancers and improve mortality rates using low-cost early detection methods. These programs will be implemented in regions where early cancer detection strategies are not in place and cancers present at advanced stages with resultant high mortality. Currently, there are three target project sites: Cambodia (June 2011), India (June 2011), and Brazil (March 2011). Memorandums of Understanding have been secured with local health organizations in each region to establish clinic operations. Each clinic would serve an approximate target population of 100,000 amongst whom about 12,000 eligible women (4-5,000 annually) will be invited to be screened for breast and cervical cancer over a three-year time span.
Detailed Description: We will study the use of sonographic screening in addition to Clinical Breast Examination in low resource settings where screening programs are not currently in place and establishing a population based mammographic screening would be expensive, resource intensive, and difficult if not impossible to implement. The effectiveness of the screening and diagnostic methodology used for early detection of breast, cervical, ovarian and endometrial cancers in low resource settings will be studied. The program would involve screening of asymptomatic women for Breast and Cervical cancer and diagnostic assessment of symptomatic women for Ovarian and Endometrial cancer. Women in the age group of 30-59 yrs will be screened once every three years utilizing the following methods: Breast - clinical breast examination \[CBE\] and Sonography, followed by Fine needle aspiration biopsy (FNAB) of screen positive cases; Cervical - Human Papilloma Virus DNA testing followed by Cryotherapy of screen positive cases (Single visit, screen and treat approach); Ovarian - Transvaginal sonogram and clinical evaluation; Endometrial - Transvaginal sonographic assessment of the endometrial stripe.
Minimum Age: 30 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Hospital de Cancer de Barretos, Sao Paolo, , Brazil
Sihanouk Hospital Center of Hope, Hope Worldwide Cambodia, Phnom Penh, , Cambodia
Manipal Healthcare Group, Goa, , India
Name: Weiwei Yang, MD
Affiliation: M.D. Anderson Cancer Center, University of Texas
Role: PRINCIPAL_INVESTIGATOR
Name: Diljeet K Singh, MD
Affiliation: Northwestern University Feinberg School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Name: Adhemar Longatto Filho, MD
Affiliation: University of Sao Paolo
Role: PRINCIPAL_INVESTIGATOR